Pet food safety debate puts regulatory effectiveness in focus

Pet food safety regulation is back under the microscope, with consumer advocate Susan Thixton arguing that the current system still accepts too little prevention for too much risk. Her latest article revisits the effectiveness question at the center of regulation: not whether rules exist, but whether they prevent enough illness, death, contamination, and misleading practices to justify public confidence. That lands at a moment when pet food oversight is already drawing broader criticism over recalls, uneven transparency, and the limits of FDA’s practical reach. (truthaboutpetfood.com)

The modern regulatory framework was shaped in large part by the 2007 melamine crisis and the later Food Safety Modernization Act, which shifted FDA’s approach toward prevention. Under FSMA’s preventive controls rule for animal food, facilities covered by the rule must conduct hazard analyses, implement risk-based preventive controls where needed, and maintain recall plans when a hazard requiring a preventive control is identified. FDA also oversees facility registration and import-related programs, including foreign supplier verification requirements. But that structure is still largely facility- and process-based, not a premarket approval system for finished pet food products. (fda.gov)

That distinction is central to the current debate. Thixton’s piece highlights FDA language estimating a modest effectiveness range for the animal food preventive controls rule, using it to argue that regulators knew the rule would leave many harms untouched. Her framing is advocacy-driven, but the underlying tension is real: FDA can require safe ingredients, sanitary production, truthful labeling, and recalls, yet it does not approve individual pet food brands or products before they reach shelves. On labeling, the system also depends heavily on state enforcement and AAFCO model regulations, which many states adopt or adapt. (truthaboutpetfood.com)

At the same time, the regulatory landscape is still evolving. AAFCO approved updated model pet food regulations that include a more standardized “Pet Nutrition Facts” format, and it recommended a six-year enforcement-discretion period tied to the 2024 Official Publication so states and manufacturers can transition. Industry groups say those changes should improve label clarity for veterinarians and pet parents, but they don’t by themselves resolve the harder questions around ingredient quality, manufacturing oversight, or how aggressively regulators should police claims and contamination risks. Separately, FDA’s longstanding memorandum of understanding with AAFCO expired in October 2024, and legal and industry observers have been watching how FDA’s animal-food ingredient oversight will adapt. (aafco.org)

Expert and industry commentary reflects that same split. WSAVA’s nutrition toolkit pushes veterinarians and pet parents to ask practical questions that go beyond bare legal compliance, including whether a company employs qualified nutrition experts, what quality control measures it uses, and whether it conducts feeding trials. In a 2025 commentary in STAT, Boston University School of Public Health policy analyst Katherine O’Malley argued that U.S. pet food regulation is already “spotty,” and pointed to recalls, the lack of product-level FDA approval, and concern about shrinking oversight capacity. That perspective is not a regulatory ruling, but it does capture a growing sentiment that formal compliance may not be enough to reassure clinicians or consumers. (wsava.org)

Why it matters: For veterinary teams, this story is really about the gap between what’s legal, what’s transparent, and what’s clinically persuasive. Veterinarians are asked every day to help pet parents choose diets, interpret recalls, and assess whether a product seems trustworthy. Yet one study found 57.1% of surveyed veterinarians reported receiving “none” or “very little” formal instruction in small animal nutrition, which may make a fragmented regulatory environment even harder to navigate in practice. In that setting, clinics may increasingly rely on structured diet-history protocols, recall monitoring, and evidence-based screening questions about manufacturer expertise, quality control, and nutritional substantiation. (pubmed.ncbi.nlm.nih.gov)

The practical implication is that veterinary professionals may need to distinguish more explicitly between minimum regulatory compliance and higher-confidence indicators of quality. A food can be lawfully marketed yet still leave unanswered questions about formulation oversight, supply-chain controls, pathogen risk, or the strength of feeding data. That’s especially relevant in categories such as raw diets, where FDA has repeatedly issued safety advisories tied to pathogens including Salmonella, Listeria monocytogenes, and E. coli. For clinicians, the safest course is often to pair regulatory awareness with manufacturer due diligence and clear communication to pet parents about known risks and unknowns. (fda.gov)

What to watch: The next phase will be less about whether pet food is regulated at all, and more about whether pending label modernization, post-2024 FDA-AAFCO coordination changes, and future enforcement activity translate into measurably better safety outcomes, fewer recalls, and more usable information for veterinary teams and pet parents. (aafco.org)